BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25755724)

  • 61. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
    Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
    Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer.
    Liu T; Wang Z; Dong M; Wei J; Pan Y
    Oncol Lett; 2021 May; 21(5):367. PubMed ID: 33747224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.
    Hu Y; Pu Q; Cui B; Lin J
    Int J Clin Exp Pathol; 2015; 8(8):8921-8. PubMed ID: 26464633
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
    Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
    Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-506 regulates breast cancer cell metastasis by targeting IQGAP1.
    Sun G; Liu Y; Wang K; Xu Z
    Int J Oncol; 2015 Nov; 47(5):1963-70. PubMed ID: 26398880
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
    Zhao S; Ye X; Xiao L; Lian X; Feng Y; Li F; Li L
    Tumour Biol; 2014 Oct; 35(10):9725-33. PubMed ID: 24972966
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα.
    Liu X; Zhang L; Tong Y; Yu M; Wang M; Dong D; Shao J; Zhang F; Niu R; Zhou Y
    Life Sci; 2019 Jan; 217():57-69. PubMed ID: 30502362
    [TBL] [Abstract][Full Text] [Related]  

  • 69. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ING5 suppresses breast cancer progression and is regulated by miR-24.
    Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
    Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulatory Axis of miR-195/497 and HMGA1-Id3 Governs Muscle Cell Proliferation and Differentiation.
    Qiu H; Zhong J; Luo L; Tang Z; Liu N; Kang K; Li L; Gou D
    Int J Biol Sci; 2017; 13(2):157-166. PubMed ID: 28255268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
    Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [MicroRNA-205 targeted Krüppel-like factor 12 and regulated MDA-MB-468 cells apoptosis in basal-like breast carcinoma].
    Guan B; Li Q; Li XH; Zhou XJ
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2070-5. PubMed ID: 27468619
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.
    Cabello P; Pineda B; Tormo E; Lluch A; Eroles P
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression.
    Huang ZM; Ge HF; Yang CC; Cai Y; Chen Z; Tian WZ; Tao JL
    Kaohsiung J Med Sci; 2019 Aug; 35(8):467-473. PubMed ID: 31063232
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.
    Gao J; Li L; Wu M; Liu M; Xie X; Guo J; Tang H; Xie X
    PLoS One; 2013; 8(6):e65138. PubMed ID: 23750239
    [TBL] [Abstract][Full Text] [Related]  

  • 77. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
    Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
    Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Study of miR-26a inhibiting epithelial-mesenchymal transition and invasion of Tu686 cell line through SMAD1.
    Fan B; Li L; Xiao DJ; Xu T
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):217-224. PubMed ID: 30657563
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer.
    Zhou LL; Dong JL; Huang G; Sun ZL; Wu J
    Braz J Med Biol Res; 2017 Jul; 50(8):e5891. PubMed ID: 28746466
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Silencing lncRNA SNHG6 suppresses proliferation and invasion of breast cancer cells through miR-26a/VASP axis.
    Li K; Ma YB; Tian YH; Xu XL; Gao Y; He YQ; Pan WT; Zhang JW; He CJ; Wei L
    Pathol Res Pract; 2019 Oct; 215(10):152575. PubMed ID: 31387807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.